C135H164ClF2N21O10 — CID 159929076
tert-butyl 4-(3,4-difluorophenyl)-3-[3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]-2-oxopropyl]piperidine-1-carboxylate;1-[2-[(4-chlorophenyl)methyl]cyclohexyl]-3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]propan-2-one;1-[(1S,2R,4R)-4-(2-methoxyethyl)-2-(3-methylphenyl)cyclopentyl]-3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]propan-2-one;1-[1-methyl-3-(oxolan-2-yl)pyrazol-5-yl]-3-(2-pyrazol-1-ylcyclohexyl)propan-2-one;1-[2-(oxolan-3-ylmethyl)pyrazol-3-yl]-3-(2-pyrazol-1-ylcyclohexyl)propan-2-one (PubChem CID 159929076) has the molecular formula C135H164ClF2N21O10 and a molecular weight of 2314.38 g/mol. Its IUPAC name is tert-butyl 4-(3,4-difluorophenyl)-3-[3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]-2-oxopropyl]piperidine-1-carboxylate;1-[2-[(4-chlorophenyl)methyl]cyclohexyl]-3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]propan-2-one;1-[(1S,2R,4R)-4-(2-methoxyethyl)-2-(3-methylphenyl)cyclopentyl]-3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]propan-2-one;1-[1-methyl-3-(oxolan-2-yl)pyrazol-5-yl]-3-(2-pyrazol-1-ylcyclohexyl)propan-2-one;1-[2-(oxolan-3-ylmethyl)pyrazol-3-yl]-3-(2-pyrazol-1-ylcyclohexyl)propan-2-one.
| Compound Name | tert-butyl 4-(3,4-difluorophenyl)-3-[3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]-2-oxopropyl]piperidine-1-carboxylate;1-[2-[(4-chlorophenyl)methyl]cyclohexyl]-3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]propan-2-one;1-[(1S,2R,4R)-4-(2-methoxyethyl)-2-(3-methylphenyl)cyclopentyl]-3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]propan-2-one;1-[1-methyl-3-(oxolan-2-yl)pyrazol-5-yl]-3-(2-pyrazol-1-ylcyclohexyl)propan-2-one;1-[2-(oxolan-3-ylmethyl)pyrazol-3-yl]-3-(2-pyrazol-1-ylcyclohexyl)propan-2-one |
|---|---|
| PubChem CID | 159929076 |
| Molecular Formula | C135H164ClF2N21O10 |
| Molecular Weight | 2314.38 g/mol |
| Exact Mass | 2312.26 |
| IUPAC Name | tert-butyl 4-(3,4-difluorophenyl)-3-[3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]-2-oxopropyl]piperidine-1-carboxylate;1-[2-[(4-chlorophenyl)methyl]cyclohexyl]-3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]propan-2-one;1-[(1S,2R,4R)-4-(2-methoxyethyl)-2-(3-methylphenyl)cyclopentyl]-3-[4-methyl-3-(1-methylpyrazol-4-yl)-1-phenylpyrazol-5-yl]propan-2-one;1-[1-methyl-3-(oxolan-2-yl)pyrazol-5-yl]-3-(2-pyrazol-1-ylcyclohexyl)propan-2-one;1-[2-(oxolan-3-ylmethyl)pyrazol-3-yl]-3-(2-pyrazol-1-ylcyclohexyl)propan-2-one |
| SMILES | COCC[C@@H]1C[C@@H](CC(=O)Cc2c(C)c(-c3cnn(C)c3)nn2-c2ccccc2)[C@H](c2cccc(C)c2)C1.Cc1c(-c2cnn(C)c2)nn(-c2ccccc2)c1CC(=O)CC1CCCCC1Cc1ccc(Cl)cc1.Cc1c(-c2cnn(C)c2)nn(-c2ccccc2)c1CC(=O)CC1CN(C(=O)OC(C)(C)C)CCC1c1ccc(F)c(F)c1.Cn1nc(C2CCCO2)cc1CC(=O)CC1CCCCC1n1cccn1.O=C(Cc1ccnn1CC1CCOC1)CC1CCCCC1n1cccn1 |
| InChI | InChI=1S/C33H37F2N5O3.C32H38N4O2.C30H33ClN4O.2C20H28N4O2/c1-21-30(40(25-9-7-6-8-10-25)37-31(21)24-18-36-38(5)19-24)17-26(41)15-23-20-39(32(42)43-33(2,3)4)14-13-27(23)22-11-12-28(34)29(35)16-22;1-22-9-8-10-25(15-22)30-17-24(13-14-38-4)16-26(30)18-29(37)19-31-23(2)32(27-20-33-35(3)21-27)34-36(31)28-11-6-5-7-12-28;1-21-29(35(27-10-4-3-5-11-27)33-30(21)25-19-32-34(2)20-25)18-28(36)17-24-9-7-6-8-23(24)16-22-12-14-26(31)15-13-22;1-23-16(14-18(22-23)20-8-4-11-26-20)13-17(25)12-15-6-2-3-7-19(15)24-10-5-9-21-24;25-19(12-17-4-1-2-5-20(17)23-10-3-8-21-23)13-18-6-9-22-24(18)14-16-7-11-26-15-16/h6-12,16,18-19,23,27H,13-15,17,20H2,1-5H3;5-12,15,20-21,24,26,30H,13-14,16-19H2,1-4H3;3-5,10-15,19-20,23-24H,6-9,16-18H2,1-2H3;5,9-10,14-15,19-20H,2-4,6-8,11-13H2,1H3;3,6,8-10,16-17,20H,1-2,4-5,7,11-15H2/t;24-,26+,30+;;;/m.1.../s1 |
| InChIKey | NZKDCGIDWRYNOA-VJYSPDBXSA-N |
| XLogP | 25.88 |
| TPSA | 320.78 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 169 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2314.38 |
| LogP ≤ 5 | 25.88 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 30 |